Low levels of adiponectin are associated with cardiovascular disease, obesity, and type 2 diabetes, reflecting the importance of adequate adiponectin in regulating insulin and atherosclerosis [17]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.